Bismuth Subsalicylates

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 20
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2019-09-18T01:00:18-04:00",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "Meaningful Drug Interaction Alerts Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This set of values contains Bismuth Subsalicylate medications),(Data Element Scope: The intent of this data element is to identify patients who are on Bismuth Subsalicylate medications. Using the Quality Data Model, this particular element will map to the Medication category.),(Inclusion Criteria: Includes RxNorm codes for Bismuth Subsalicylate medications.),(Exclusion Criteria: Excludes RxNorm codes for topical forms of Bismuth Subsalicylate medications.)",
  "name" : "BismuthSubsalicylates",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1191695",
      "display" : "bismuth subsalicylate 525 MG Oral Powder",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "308760",
      "display" : "bismuth subsalicylate 262 MG Oral Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "308761",
      "display" : "bismuth subsalicylate 262 MG Chewable Tablet",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "308762",
      "display" : "bismuth subsalicylate 17.5 MG/ML Oral Suspension",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "308763",
      "display" : "bismuth subsalicylate 35 MG/ML Oral Suspension",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "422011",
      "display" : "bismuth subsalicylate 17.4 MG/ML Oral Suspension",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "616343",
      "display" : "bismuth subsalicylate 105 MG/ML Oral Suspension",
      "version" : "04012024"
    } ],
    "total" : 7,
    "identifier" : "urn:uuid:c875d599-3ee6-482a-b257-1286d6a745b4",
    "timestamp" : "2024-04-23T11:16:53-04:00"
  },
  "title" : "Bismuth Subsalicylates",
  "extension" : [ {
    "valueString" : "Meaningful Drug Interaction Alerts Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2022-12-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2019-09-18",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "198ecda6-efbe-4a5b-ac46-18b4242475b1",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.28",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1213.28"
  } ],
  "version" : "20190918"
}